Fig. 6From: Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcomaSpecimen radiograph displaying markers for each habitat and to help orient with preoperative imaging (A). At time of pathological evaluation, the specimen is mapped to a grid to determine percentage of pathological response throughout the specimen (B)Back to article page